KARDIOLOGIYA

Scope & Guideline

Pioneering Research in Heart Health

Introduction

Delve into the academic richness of KARDIOLOGIYA with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageRussian
ISSN0022-9040
PublisherRUSSIAN HEART FAILURE SOC
Support Open AccessNo
CountryRussian Federation
TypeJournal
Convergefrom 1961 to 2024
AbbreviationKARDIOLOGIYA / Kardiologiya
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address215, 5, BEREGOVOY PROEZD, MOSCOW 121087, RUSSIA

Aims and Scopes

KARDIOLOGIYA focuses on advancing the field of cardiology through comprehensive research that addresses a wide spectrum of cardiovascular diseases, diagnostic techniques, and treatment methodologies. The journal emphasizes clinical applications, innovative therapies, and the integration of emerging scientific insights into cardiovascular care.
  1. Cardiovascular Disease Mechanisms and Pathophysiology:
    Research exploring the underlying mechanisms of various cardiovascular conditions, including myocardial infarction, heart failure, and arrhythmias, is a core focus. This includes studies on biomarkers, genetic predispositions, and the effects of comorbidities such as diabetes and hypertension.
  2. Innovative Diagnostic and Therapeutic Techniques:
    KARDIOLOGIYA publishes studies on modern diagnostic methods, such as echocardiography, CT angiography, and cardiac MRI, along with evaluations of novel therapeutic approaches including pharmacological treatments and interventional procedures.
  3. Management of Chronic Heart Failure:
    Significant attention is given to the management strategies for chronic heart failure, including the latest insights into pharmacotherapy, rehabilitation, and the use of devices like implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy.
  4. Cardio-Oncology:
    The intersection of cardiology and oncology is increasingly represented, with research addressing cardiotoxicity from cancer therapies and the management of cardiovascular risks in cancer patients.
  5. Public Health and Cardiovascular Epidemiology:
    The journal also emphasizes epidemiological studies that assess risk factors, prevalence rates, and population health outcomes related to cardiovascular disease, particularly in the context of the Russian Federation.
KARDIOLOGIYA has shown a remarkable adaptability to emerging trends in cardiology, reflecting contemporary challenges and advancements in the field. The following themes have gained prominence in recent publications, indicating a shift in research focus.
  1. Telemedicine and Remote Monitoring:
    The increasing reliance on telemedicine for cardiovascular care, particularly post-COVID-19, highlights the importance of remote monitoring and digital health technologies in managing chronic cardiovascular diseases.
  2. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Research focusing on HFpEF has surged, addressing its complex pathophysiology, diagnosis, and management strategies, reflecting growing recognition of this condition's prevalence and impact.
  3. Cardio-Oncology Research:
    The intersection of cardiology and oncology is increasingly represented, with a focus on understanding and mitigating the cardiovascular effects of cancer treatments, emphasizing the need for integrated care models.
  4. The Role of Inflammation in Cardiovascular Disease:
    Emerging studies are increasingly focusing on inflammatory processes as key contributors to cardiovascular pathology, integrating findings from immunology into cardiovascular research.
  5. Personalized Medicine in Cardiovascular Care:
    There's a growing trend towards personalized approaches in treating cardiovascular diseases, including the use of genetic and biomarker data to tailor therapies to individual patients.

Declining or Waning

Over recent years, certain themes within KARDIOLOGIYA have seen a decline in focus. This may reflect evolving clinical priorities, shifts in research funding, or the completion of earlier research agendas.
  1. Traditional Risk Factor Studies:
    While risk factors such as hypertension and hyperlipidemia remain relevant, there has been a noticeable decrease in studies focusing solely on these traditional risk factors without integrating newer biomarkers or genetic information.
  2. Basic Science Research on Cardiovascular Pathways:
    Research that delves into the fundamental biological mechanisms of cardiovascular diseases, such as cellular signaling pathways without clinical application, appears to be waning in favor of studies with direct clinical implications.
  3. Invasive Surgical Techniques:
    There is a shift away from traditional surgical methodologies towards less invasive procedures and medical management, leading to fewer publications on invasive surgical techniques and their outcomes.

Similar Journals

CURRENT PROBLEMS IN CARDIOLOGY

Transforming Challenges into Cardiac Innovations
Publisher: MOSBY-ELSEVIERISSN: 0146-2806Frequency: 12 issues/year

CURRENT PROBLEMS IN CARDIOLOGY is a leading peer-reviewed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of cardiology through comprehensive analyses of contemporary challenges faced by cardiovascular practitioners. With its ISSN 0146-2806 and E-ISSN 1535-6280, this esteemed journal has been a crucial resource for researchers, clinicians, and students alike since its inception in 1976, and continues to publish groundbreaking studies and reviews up until 2024. As a testament to its scholarly impact, CURRENT PROBLEMS IN CARDIOLOGY boasts a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine, as well as in the broader category of Medicine (miscellaneous) in the 2023 metrics, positioning it among the top journals in its field. With a Scopus ranking of #127 out of 387 in Cardiology, and a 67th percentile ranking, it remains a vital platform for disseminating high-quality research that addresses critical issues in cardiovascular health. Researchers and practitioners looking to stay at the forefront of cardiac medicine will find this journal an indispensable tool for informed decision-making and practice improvement.

Kardiologie

Bridging Research and Practice in Cardiology.
Publisher: SPRINGER HEIDELBERGISSN: 2731-7129Frequency: 6 issues/year

Kardiologie is an emerging journal dedicated to advancing the field of cardiology and cardiovascular medicine, published by SPRINGER HEIDELBERG in Germany. Established with the first issue in 2022, this journal provides a valuable platform for the dissemination of innovative research, clinical studies, and review articles that contribute to both theoretical knowledge and practical applications in cardiology. While the journal currently holds a Q4 category ranking in the field and occupies a percentile of 24 according to Scopus, it aims to enhance its impact factor by attracting high-quality submissions from researchers and clinicians alike. Kardiologie is particularly focused on bridging the gap between cutting-edge research and clinical practice, ensuring that the latest scientific findings are readily accessible to practitioners. Though it operates under traditional access options at present, the journal aspires to broaden its accessibility and reach in future editions, making it a pertinent choice for anyone interested in the evolving landscape of cardiovascular health.

Arquivos Brasileiros de Cardiologia

Fostering collaboration and innovation in cardiovascular health.
Publisher: ARQUIVOS BRASILEIROS CARDIOLOGIAISSN: 0066-782XFrequency: 12 issues/year

Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.

Journal of the Saudi Heart Association

Transforming Heart Health Through Scholarly Excellence
Publisher: DIGITAL COMMONS BEPRESSISSN: 1016-7315Frequency: 4 issues/year

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.

CARDIOVASCULAR RESEARCH

Innovating research for a healthier heart.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

CIRCULATION

Exploring the Frontiers of Cardiovascular Medicine.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0009-7322Frequency: 50 issues/year

CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.

International Journal of Angiology

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: THIEME MEDICAL PUBL INCISSN: 1061-1711Frequency: 4 issues/year

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

Netherlands Heart Journal

Transforming Cardiology Insights into Global Health Solutions
Publisher: BOHN STAFLEU VAN LOGHUM BVISSN: 1568-5888Frequency: 12 issues/year

Netherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.

American Journal of Cardiovascular Drugs

Transforming Cardiovascular Care Through Research
Publisher: ADIS INT LTDISSN: 1175-3277Frequency: 6 issues/year

American Journal of Cardiovascular Drugs, published by ADIS INT LTD, is a premier peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. With an ISSN of 1175-3277 and an E-ISSN of 1179-187X, this esteemed journal has established itself as a crucial platform for disseminating high-quality research since its inception in 2001. It holds a significant position in its domain, ranking in the second quartile (Q2) across several categories including Cardiology, Medicine (miscellaneous), and Pharmacology (medical) for the year 2023. With its Scopus ranks placing it in the 81st percentile for Cardiology and 77th percentile for Pharmacology, the journal is highly regarded among professionals, researchers, and students alike. While it is not an open-access journal, its comprehensive articles and systematic reviews provide an in-depth exploration of cardiovascular drug therapy, therapeutic advancements, and clinical practices, making it an invaluable resource for anyone invested in the future of cardiovascular health.

Anatolian Journal of Cardiology

Connecting Global Hearts with Cutting-edge Cardiovascular Knowledge.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.